News
GLP-1 agonists like Wegovy, Ozempic, and Mounjaro might benefit heart and brain health—but research suggests they might also ...
The UK’s MHRA and Genomics England have launched a groundbreaking study to investigate whether genetics play a role in ...
UK-based celebrity nutritionist Rose Ferguson previously revealed an uptick in the her clients who are worried about facial ...
Patients prescribed Mounjaro - dubbed the 'King Kong' of injections due to its potency - took to social media concerned they ...
At least 10 people have now died following side-effects allegedly caused by GLP-1 weight loss jabs. Over a million people ...
The weight-loss injection boom that swept through Hollywood and boardrooms alike is now facing a potentially deadly reckoning ...
Access is opening up for Kiwis to a weight loss drug described as a game changer. Wegovy, made by pharma-co Novo Nordisk, ...
Indian drugmaker Biocon has abandoned plans to market generic versions of Novo Nordisk’s hot-selling diabetes and weight-loss drugs in China due to local competition, a senior executive said.
Dr. Ambish Mithal unpacks the world of new-age weight management drugs, their side effects, their benefits and what lies ...
Biocon cancels plans to market Novo Nordisk generics in China due to local competition, focusing on other markets.
Recent years have seen the advent of weight loss drugs, including Ozempic and Wegovy. They work by suppressing users' ...
Women on Mounjaro may miss signs of pancreatitis. Learn the symptoms, risks, and what UK health authorities are doing to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results